# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Oramed Pharmaceuticals (NASDAQ:ORMP) with a Neutral.
David will join Compugen from Oramed Pharmaceuticals Inc., where he served as Chief Financial Officer.
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a...
-8-K
An initial principal balance of $101,875,000.00; A senior lien for Oramed on substantially all assets of Scilex and its subs...
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focuse...
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")))), an innovative revenue-generating company focuse...